Driving innovation in biotechnology
Ebovir Biotechnologies Inc., headquartered in Montreal, Quebec, was founded in 2021 incubated from McGill University. We are committed to driving innovation in the biotechnology field and has become a key partner to numerous biopharmaceutical companies.
Ebovir locates in the heart of Quebec's life sciences hub — the CQIB Life Sciences Incubator. It is a member of BioQuebec and RNACanada, deeply integrated into Canada's thriving life sciences ecosystem.
- Founded
- 2021
- Incubated from
- McGill University
- Lab capabilities
- BSL-2 & BSL-3
- Recognition
- Canada Top 10 Therapeutic Co. (2024)
Ebovir operates one of North America's most advanced private diagnostic laboratories in Canada (with BSL-2 and BSL-3 capabilities), offering comprehensive services for virology research and preclinical drug development. We focus on early cancer screening and whole genome sequencing (WGS), and is actively developing anti-aging and wellness products based on exosomes and lipid nanoparticles (LNPs).
Investissement Québec has recognized Ebovir as a recommended biotechnology company for Asia-Pacific market expansion, underscoring our potential for global growth.
With significant breakthroughs in the development of antiviral therapies, Ebovir was named one of Canada's Top 10 Therapeutic Companies in 2024, highlighting its strong scientific capabilities.
Powered by world-class research platforms, we accelerate the clinical translation of precision medicine and regenerative technologies while promoting international collaboration.
Bringing precision to the science of better health
Ebovir was founded in 2021 and incubated from McGill University with a clear purpose: to make precision medicine more accurate, more personal, and more accessible. We pair advanced molecular biology with AI-driven analysis to help people and partners understand health at the level of the genome.
Innovation-Driven
We develop and apply cutting-edge AI-powered analysis, genetic screening, and advanced diagnostics to deliver safe, effective, personalized solutions.
Precision Medicine
Through AI-integrated genomic testing and early cancer screening, we work to improve the accuracy of disease prevention and personalized care.
Clinical Translation
Our one-stop CRO platform supports biopharma companies and research institutions in accelerating new therapeutics and diagnostics.
Global Collaboration
We partner with research institutions, medical centers, and biopharmaceutical companies to advance precision medicine internationally.
Built on laboratory expertise
Ebovir's science is grounded in real laboratory capability and recognized affiliations within Québec's life-sciences community.
BSL-2 & BSL-3 capabilities
Operating one of North America's advanced private diagnostic laboratories for virology research and preclinical drug development.
Incubated from McGill University
Founded in 2021 and incubated from McGill University, now located in the CQIB Life Sciences Incubator.
Recognized affiliations
A member of BioQuébec and RNACanada, within Québec's life-sciences hub.
Industry recognition
Named one of Canada's Top 10 Therapeutic Companies in 2024, and recommended by Investissement Québec for Asia-Pacific expansion.
Operating to recognized laboratory standards
EBOVIR's laboratory work is conducted under established biosafety and quality practices appropriate to its BSL-2 and BSL-3 capabilities, with research products provided for research use only (RUO) unless otherwise specified.
Laboratory operations follow universal-precaution handling and biosafety oversight, supported by a dedicated biosafety officer within our affiliated research network.
EBOVIR is a member of BioQuébec and RNACanada, and operates within the CQIB Life Sciences Incubator in Québec's life-sciences community.
The minds behind Ebovir
Meet the innovative minds driving Ebovir's mission to revolutionize biotechnology and advance scientific discovery.
Executive Leadership
Our visionary leaders guiding Ebovir's strategic direction and innovation.
Dr. Zhenlong Liu
Founder & CEO
Visionary leader with extensive experience in biotechnology and business development. Passionate about leveraging cutting-edge science to address global health challenges.
Dr. Chen Liang
Co-Founder
Senior Investigator, Lady Davis Institute for Medical Research; Professor, Graduate Program in Clinical and Translational Research, McGill University.
Dr. Benoit Barbeau
Co-Founder
Professor; Associate member of the interdisciplinary research center on well-being, health, society and the environment, University of Quebec in Montreal.
Dr. Rongtuan Lin
Co-Founder
Senior Investigator, Lady Davis Institute for Medical Research; Associate Professor, Department of Medicine, McGill University.
Advisory Team
Distinguished experts providing strategic guidance and industry insights.
Scientific Advisors
Dr. Chen Liang
Scientific Advisor
Senior Investigator, Lady Davis Institute for Medical Research; Professor, Graduate Program in Clinical and Translational Research, McGill University.
Guojun Chen
Scientific Advisor
Assistant Professor, Department of Biomedical Engineering; Associate Member, Rosalind and Morris Goodman Cancer Institute.
Dr. Benoit Barbeau
Scientific Advisor
Professor; Associate member of the interdisciplinary research center on well-being, health, society and the environment, University of Quebec in Montreal.
Dr. Rongtuan Lin
Scientific Advisor
Senior Investigator, Lady Davis Institute for Medical Research; Associate Professor, Department of Medicine, McGill University.
Dr. Rob Scarborough
Scientific Advisor
Prevention Management and Biosafety Officer, Health, Safety and Well-being in the Workplace (SSMET) service, Administration, Lady Davis Institute for Medical Research.
Medical Advisors
Dr. Zuhua Gao
Medical Advisor
Professor and Department Head, Pathology and Laboratory Medicine; Staff Pathologist and Program Medical Director, Provincial Pathology & Laboratory Medicine, BC Cancer, The University of British Columbia.
Dr. Yaning Gao
Medical Advisor
Experienced clinician providing medical insights and clinical perspective to guide product development and validation.
Dr. Michele Rainville
Medical Advisor
Medical expert contributing clinical knowledge and healthcare industry experience to our advisory board.
Dr. Shuaa Basalom
Medical Advisor
Medical professional providing valuable insights into clinical applications and healthcare implementation strategies.
AI Advisors
Dr. Yuhong Yan
AI Advisor
Associate Professor, Concordia University. Artificial intelligence expert with deep knowledge in machine learning applications for biotechnology and healthcare.
Dr. Jian Zhao
AI Advisor
Associate Professor, University of Waterloo. Technology leader specializing in AI/ML solutions for complex scientific and medical challenges.
Operational Team
Dedicated professionals executing our vision across laboratory, AI, and business operations.
Laboratory Team
Dr. Sabrine Najeh
Certified Microbiologist; COO & Laboratory Director; Nucleic Acids Engineering Expert
Dr. Liseth Carmona
Stem Cells and Immunology Expert
Xiaoying Han
Scientist; Small RNAs Expert
Pierre-Luc
RCA Expert